Edwards Lifesciences
EW
NYSE
IPO2000
about EW
Edwards Lifesciences is a global leader in developing and marketing innovative medical devices, particularly focused on cardiovascular care, including advanced heart valve technologies and minimally invasive solutions to improve patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $80.17 | $80.45 | $79.07 | $47.09B | 237.33K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.57 | 11.46 | 30.38 | 26.84% | 21.64% | 0% |